Applied Genetic Technologies Corporation (NASDAQ:AGTC) belongs to Healthcare sector. Its weekly performance is -6.36%. On last trading day company shares ended up $17.82. Applied Genetic Technologies Corporation (NASDAQ:AGTC) distance from 50-day simple moving average (SMA50) is -2.16%. On 2 July, Applied Genetic Technologies Corporation (NASDAQ:AGTC) said that, Biogen Inc. will enter the field of eye-disease treatment by paying Applied Genetic Technologies Corp. $124 million for license and commercialization rights to several of its gene-based therapies.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares increased 0.58% in last trading session and ended the day at $15.49. BCRX Gross Margin is 100.00% and its return on assets is -36.80%. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) quarterly performance is 60.52%. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) was upgraded by equities researchers at Bank of America from a “neutral” rating to a “buy” rating in a research report issued on Tuesday. The firm currently has a $19.00 target price on the biotechnology company’s stock, up from their previous target price of $12.00. Bank of America’s target price indicates a potential upside of 27.26% from the stock’s previous close.
On 10 July, Western Alliance Bancorporation (NYSE:WAL) shares increased 1.22% and was closed at $34.12. WAL EPS growth in last 5 year was 21.40%. Western Alliance Bancorporation (NYSE:WAL) year to date (YTD) performance is 22.73%. Western Alliance Bancorporation (NYSE:WAL) announced that the Company will now release its second quarter 2015 financial results on Monday, July 27, 2015 before the market opens. Chairman and CEO Robert Sarver and CFO Dale Gibbons will host a conference call at 12:00 p.m. ET on the same day to discuss the Company’s performance.
StemCells Inc. (NASDAQ:STEM) ended the last trading day at $0.52. Company weekly volatility is calculated as 7.56% and price to cash ratio as 3.87. StemCells Inc. (NASDAQ:STEM) showed a weekly performance of -1.98%. On 9 July, StemCells Inc. (NASDAQ:STEM) said that, it has posted a video of the presentation made by the Company’s vice president of clinical research and chief medical officer Dr. Stephen Huhn, at the ISSCR 2015 Annual Meeting. Held last month in Stockholm, the meeting was attended by approximately 3,000 scientists, clinicians and biotechnology industry professionals from 55 countries, who gathered to share new data and discuss advances within the stem cell field that are currently being explored by peers as potential therapeutic treatments.
Gladstone Land Corporation (NASDAQ:LAND) shares increased 1.29% in last trading session and ended the day at $10.99. LAND Gross Margin is 79.50% and its return on assets is -0.10%. Gladstone Land Corporation (NASDAQ:LAND) quarterly performance is -8.67%.On 2 July, Gladstone Land Corporation (NASDAQ:LAND) announced that it has acquired 2,668 acres of land with 1,664 farmable acres in Hendry County, Florida, for approximately $15.8 million. The Company entered into a 5-year lease agreement with a leading grower and marketer of fresh vegetables. The lease provides for annual escalations and two 5-year extension options.